Health Food Toxicology Testing: Standards, Test Items, and Safety Evaluation Procedures

Health food toxicology testing is a systematic safety evaluation program required to demonstrate that dietary supplements and functional food products are safe for human consumption under intended use conditions. Conducted in accordance with the GB 15193 national food safety standards, OECD test guidelines, and GLP principles, these studies form the core toxicological dossier for health food registration, filing, and market access. Accredited third-party laboratories provide a full range of tests, from acute oral toxicity and genotoxicity batteries to repeated-dose, reproductive, and chronic toxicity studies.

Technical Overview

Toxicological evaluation of health foods (dietary supplements and functional foods) is a risk-based, tiered assessment designed to identify potential adverse effects of a product or ingredient before it reaches consumers. In China, the framework is defined by the GB 15193 series of national food safety standards, most notably GB 15193.1, which specifies the procedure for toxicological assessment of food, together with the safety evaluation requirements published by the national medical products regulator for health food registration and filing. Internationally, equivalent studies follow OECD test guidelines and the safety assessment expectations of authorities such as the US FDA and the European Food Safety Authority (EFSA).

The evaluation follows a sequential strategy: hazard identification begins with acute oral toxicity testing, proceeds through a battery of genotoxicity assays, and, where warranted, extends to repeated-dose studies (28-day and 90-day), developmental and reproductive toxicity studies, and in certain cases chronic toxicity or carcinogenicity studies. The scope of testing is determined by the nature of the ingredients, the availability of safe-use history, and the intended population and consumption levels. All studies must be performed in qualified facilities operating under recognized laboratory practice standards, and reports from accredited third-party laboratories are widely accepted by regulators for registration submissions.

Testing Samples

Finished Health Food Products

Complete market-form products in their final dosage form, including tablets, hard and soft capsules, oral liquids, powders, granules, and functional beverages. Samples should represent the commercial formulation, with all active ingredients and excipients identical to the intended registered product.

Raw Materials and Botanical Extracts

Individual ingredients such as plant extracts, herbal raw materials, protein concentrates, peptides, dietary fibers, and bioactive compounds. These are tested when the ingredient is not included in an approved raw material directory or lacks a documented history of safe consumption.

Novel and Newly Developed Ingredients

New food ingredients, newly developed compound formulations, ingredients produced by new processes or fermentation technology, and substances with no traditional food use, which generally require the most comprehensive toxicological data packages.

Sample Submission Requirements

• Sufficient quantity to cover all requested study arms, dose groups, and reserve samples, typically calculated based on dosage form, dose levels, and study duration.
• Three production batches are generally recommended for registration dossiers, with homogeneity and stability documentation.
• Complete product information: formula, ingredient specifications, recommended daily intake, production process, and quality standards.
• Samples must be within shelf life, properly packaged, labeled, and transported under suitable conditions to preserve integrity.

Testing Items

The test program is tailored to the ingredient risk category, in line with the tiered principles of GB 15193.1 and the applicable health food safety evaluation requirements:

• Acute oral toxicity test: determination of LD50 or a limit test in rodents to characterize short-term toxicity and provide dose-setting information for subsequent studies.
• Genotoxicity battery: bacterial reverse mutation test (Ames test); mammalian erythrocyte micronucleus test or mammalian bone marrow chromosome aberration test; mouse sperm abnormality test, or in vitro mammalian cell assays such as the mouse lymphoma TK gene mutation test and chromosome aberration test as alternatives.
• 28-day repeated-dose oral toxicity test: short-term subacute study in rats examining general toxicity, hematology, clinical chemistry, and histopathology.
• 90-day subchronic oral toxicity test: extended repeated-dose study to establish no-observed-adverse-effect levels (NOAEL) for ingredients with limited consumption history.
• Developmental and reproductive toxicity tests: teratogenicity study and reproductive toxicity study assessing effects on fertility, embryonic development, and offspring.
• Chronic toxicity and carcinogenicity studies: required only for high-risk categories or ingredients with structural alerts, typically combined chronic toxicity and carcinogenicity designs.
• Toxicokinetics and metabolism studies: absorption, distribution, metabolism, and excretion characterization for ingredients requiring mechanistic safety data.

Testing Methods

Studies are conducted using validated protocols that harmonize national food safety standards with internationally recognized methods:

• Acute toxicity is performed per GB 15193.3 and OECD TG 420/423/425, using the fixed-dose, acute toxic class, or up-and-down procedures with oral gavage administration.
• Genotoxicity assays follow GB 15193.4 through GB 15193.8 and OECD TG 471 (Ames), TG 474 (micronucleus), TG 473/TG 475 (chromosomal aberration), and TG 490 (mouse lymphoma assay), with and without metabolic activation.
• Repeated-dose studies follow the GB 15193 series and OECD TG 407 (28-day) and TG 408 (90-day), with at least three dose levels plus a control group, monitoring clinical signs, body weight, food and water consumption, functional observations, and full laboratory and histopathological examinations.
• Reproductive and developmental studies apply OECD TG 414 (prenatal developmental toxicity) and TG 416 (two-generation reproductive toxicity) adapted to the relevant national procedures.
• Test systems use healthy laboratory rodents (mice and rats) from qualified suppliers, maintained under animal welfare and 3Rs principles (replacement, reduction, refinement), with ethical review and humane endpoints documented.
• Laboratories operate under food toxicology good laboratory practice provisions (GB 15193.2) and quality management systems consistent with ISO/IEC 17025 accreditation, ensuring data traceability and report acceptance by regulatory authorities.

Applications

• Health food registration and filing submissions to regulatory authorities, where the toxicology report is a mandatory technical document for product approval.
• Safety dossiers for new food ingredient and novel food approvals in domestic and international jurisdictions.
• Export compliance, supporting notifications and submissions such as US FDA new dietary ingredient notifications, EU novel food applications, and EFSA safety assessments.
• Research and development screening, allowing formulators to compare ingredient safety profiles, set safe dosage ranges, and refine formulations before registration.
• Risk assessment and post-market evaluation, providing scientific evidence for responding to adverse event inquiries, safety re-evaluations, and regulatory consultations.

FAQ

Which toxicology tests are required for health food registration?

The scope depends on ingredient category. Products composed entirely of directory-listed raw materials with established food use typically require no additional testing. Ingredients with safe consumption history but outside the directory generally require acute toxicity plus the genotoxicity battery. Ingredients lacking consumption history require the addition of 28-day studies, and high-novelty ingredients may require 90-day, teratogenicity, or reproductive toxicity studies.

How long does a complete toxicology evaluation take?

Acute toxicity studies usually complete within two to four weeks, genotoxicity batteries within six to ten weeks, 28-day studies within eight to twelve weeks, and 90-day studies within four to six months, excluding sample preparation and report review. A full tiered program should be scheduled across several months to a year.

How much sample is needed?

Sample quantity depends on the test battery, number of dose groups, animal numbers, and study duration. As a practical guideline, laboratories calculate required amounts from the highest planned dose and body weights of the animals; clients should confirm exact quantities with the testing laboratory before submission.

Are the tests performed on animals?

Yes, the standard battery uses rodent models and in vitro cell and bacterial systems. All animal work must comply with national laboratory animal management regulations and 3Rs principles, and in vitro alternatives are used wherever scientifically valid to reduce animal use.

Which standards govern the testing?

The GB 15193 national food safety standard series governs procedures in China, complemented by OECD test guidelines for internationally harmonized studies. Reports must be issued by laboratories qualified for food safety toxicology testing, and reports from accredited third-party laboratories are accepted for regulatory submissions.

What conclusions are provided in the report?

Reports identify target organs and dose-response relationships, establish LD50 or NOAEL values where applicable, evaluate genotoxic potential, and provide an overall safety conclusion relative to the recommended human intake, supporting the risk assessment conclusion required for product approval.